US FDA Could Miss User Fee Spending Triggers With House FY 2026 Funding

 
• By Sarah Karlin-Smith and Derrick Gingery
  
Sign that reads "Warning! Trigger"
The House FY 2026 FDA appropriations bill could force non-user fee program cuts to ensure minimum spending levels are met, agency sources told the Pink Sheet. (Shutterstock)

More from User Fees

More from Legislation